S'abonner

Relative vaccine protection, disease severity, and symptoms associated with the SARS-CoV-2 omicron subvariant BA.2.86 and descendant JN.1 in Denmark: a nationwide observational study - 22/08/24

Doi : 10.1016/S1473-3099(24)00220-2 
Ida Rask Moustsen-Helms, PhD a, Peter Bager, PhD b, Tine Graakjær Larsen, MD a, d, Frederik Trier Møller, PhD a, Lasse Skafte Vestergaard, PhD a, Morten Rasmussen, PhD c, Christian Holm Hansen, PhD a, e,
for the

SSI-DMC Study Group

  Members listed at the end of the Article
Lasse Engbo Christiansen, Sophie Gubbels, Ramona Trebbien, Casper Westergaard, Leandro Andrés Escobar-Herrera, Vithiagaran Gunalan, Aleksander Ring, Marc Bennedbæk, Nina Steenhard, Esben Mørk Hartmann, Lene Nielsen, Dorte Terp Andersen, Marianne Kragh Thomsen, Ea Sofie Marmolin, Thomas Vognbjerg Sydenham, Silje Vermedal Hoegh, Mette Pinholt, Josefine Tange Møller, Tina Vasehus Madsen, David Fuglsang-Damgaard, Pikka Jokelainen, Tyra Grove Krause, Henrik Ullum, Bolette Søborg, Palle Valentiner-Branth

a Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark 
b Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark 
c Department of Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark 
d ECDC Fellowship Programme, Public Health Microbiology path (EUPHEM), European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden 
e MRC International Statistics and Epidemiology Group, London School of Hygiene & Tropical Medicine, London, UK 

* Correspondence to: Dr Christian Holm Hansen, Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, 2300 Copenhagen, Denmark Department of Infectious Disease Epidemiology and Prevention Statens Serum Institut Copenhagen 2300 Denmark

Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.

Connectez-vous pour en bénéficier!

Summary

Background

During the 2023 Danish COVID-19 vaccination campaign, an updated monovalent mRNA vaccine targeting the SARS-CoV-2 omicron XBB.1.5 subvariant was administered. However, the rapid spread of a genetically divergent omicron BA.2.86 subvariant, JN.1, since September, 2023, poses potential challenges due to its rapid dominance and possible immune escape. Using national electronic health registry data from all regions of Denmark, we aimed to investigate whether the SARS-CoV-2 subvariant BA.2.86, and its descendant JN.1, differed from other circulating variants in terms of their ability to escape vaccine protection, the risk of infection leading to severe disease, and self-reported symptoms among infected people.

Methods

In this observational study, we included all residents of Denmark aged 65 years and older who tested positive for SARS-CoV-2 by PCR between Oct 1 and Dec 31, 2023, and for whom genomic data on the SARS-CoV-2 variant that had caused their infection were available. Data from clinical testing, sentinel, and self-sampling-based surveillance were linked with national electronic civil, vaccination, and hospitalisation registers. The relative protection of the XBB.1.5 updated COVID-19 vaccine against BA.2.86 infections versus infections with other variants was analysed in a case-only study, and the relative risk of hospitalisation in people infected with BA.2.86 versus other variants was analysed in a case–control study. Both analyses were adjusted for time, comorbidities, and previous vaccination history, among other potential confounders. Additionally, prevalence patterns in self-reported symptoms among people of all ages infected with SARS-CoV-2 were reported separately by subvariant.

Findings

Of the 7581 people in Denmark aged 65 years or older who tested positive for SARS-CoV-2 by PCR during the study period, 5882 (78%) samples were eligible for sequencing. 3862 (66%) of these passed quality control, were successfully sequenced, and the SARS-CoV-2 variant and subvariant identified, and these individuals were included in the study. Of these 3862 people, 2184 (57%) were infected with the BA.2.86 subvariant, including 1615 JN.1 infections. Participants infected with BA.2.86 had 1·52 (95% CI 1·25–1·86) times the odds, and those infected with JN.1 had 1·60 (1·27–2·02) times the odds, of having received the XBB.1.5 vaccine at least 7 days before their infection compared with participants infected with a non-BA.2.86 variant. The severity analysis showed no evidence of association between the infecting variant and the risk of COVID-19 hospitalisation (odds ratio 1·04 [95% CI 0·86–1·26] for BA.2.86 and 1·07 [0·85–1·34] for JN.1). Similarly, there was no evidence of differences in self-reported symptoms by variant strain.

Interpretation

Compared with other SARS-CoV-2 variants, BA.2.86 and the JN.1 sublineage were less sensitive to vaccine-induced immune protection from the XBB.1.5 updated COVID-19 vaccine; however, we found no evidence that infection with BA.2.86 or JN.1 resulted in increased disease severity or different symptom profiles. Although less effective against the new variants, XBB.1.5 vaccination remains protective and reduces the risk of infection and COVID-19 disease.

Funding

The Danish Government and the EU’s EU4Health programme.

Le texte complet de cet article est disponible en PDF.

Plan


© 2024  Elsevier Ltd. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 24 - N° 9

P. 964-973 - septembre 2024 Retour au numéro
Article précédent Article précédent
  • Temporal changes in SARS-CoV-2 clearance kinetics and the optimal design of antiviral pharmacodynamic studies: an individual patient data meta-analysis of a randomised, controlled, adaptive platform study (PLATCOV)
  • Phrutsamon Wongnak, William H K Schilling, Podjanee Jittamala, Simon Boyd, Viravarn Luvira, Tanaya Siripoon, Thundon Ngamprasertchai, Elizabeth M Batty, Shivani Singh, Jindarat Kouhathong, Watcharee Pagornrat, Patpannee Khanthagan, Borimas Hanboonkunupakarn, Kittiyod Poovorawan, Mayfong Mayxay, Kesinee Chotivanich, Mallika Imwong, Sasithon Pukrittayakamee, Elizabeth A Ashley, Arjen M Dondorp, Nicholas P J Day, Mauro M Teixeira, Watcharapong Piyaphanee, Weerapong Phumratanaprapin, Nicholas J White, James A Watson, PLATCOV Collaborative Group, James Callery, Cintia Cruz, Walter Taylor, Janjira Thaipadungpanit, Maneerat Ekkapongpisit, Varaporn Kruabkontho, Thatsanun Ngernseng, Jaruwan Tubprasert, Mohammad Abdad, Srisuda Keayarsa, Orawan Anunsittichai, Maliwan Hongsuwan, Yutatirat Singhaboot, Wanassanan Madmanee, Runch Tuntipaiboontana, Amornrat Promsongsil, Manisaree Saroj, Kanokon Suwannasin, Ellen Beer, Tanatchakorn Asawasriworanan, Stuart Blacksell, Salwaluk Panapipat, Naomi Waithira, Joel Tarning, Nuttakan Tanglakmankhong, Pedro J Almeida, Renato S Aguiar, Fernando Ascencao, Lisia Esper, Manivanh Vongsouvath, Koukeo Phommasone, Audrey Dubot-Pérès, Sisouphanh Vidhamaly, Ammala Chingsanoon, Sixiong Bisayher, Danoy Chommanam, Terry Evans, Vayouly Vidhamaly, Latsaniphone Boutthasavong, Susath Vongphachanh, Manus Potaporn, Attasit Srisubat, Bootsakorn Loharjun, M Asim Beg, Abdul Momin Kazi, Farah Qamar, Najia Ghanchi, Syed Faisal Mahmood, Pongtorn Hanboonkunupakarn, Sakol Sookprome, Vasin Chotivanich, Wiroj Ruksakul, Chunlanee Sangketchon
| Article suivant Article suivant
  • Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021
  • GBD 2021 Lower Respiratory Infections and Antimicrobial Resistance Collaborators, Rose Grace Bender, Sarah Brooke Sirota, Lucien R Swetschinski, Regina-Mae Villanueva Dominguez, Amanda Novotney, Eve E Wool, Kevin S Ikuta, Avina Vongpradith, Emma Lynn Best Rogowski, Matthew Doxey, Christopher E Troeger, Samuel B Albertson, Jianing Ma, Jiawei He, Kelsey Lynn Maass, Eric A.F.Simões, Meriem Abdoun, Jeza Muhamad Abdul Aziz, Deldar Morad Abdulah, Samir Abu Rumeileh, Hasan Abualruz, Salahdein Aburuz, Abiola Victor Adepoju, Rishan Adha, Wirawan Adikusuma, Saryia Adra, Ali Afraz, Shahin Aghamiri, Antonella Agodi, Amir Mahmoud Ahmadzade, Haroon Ahmed, Ayman Ahmed, Karolina Akinosoglou, Tareq Mohammed Ali AL-Ahdal, Rasmieh Mustafa Al-amer, Mohammed Albashtawy, Mohammad T. AlBataineh, Hediyeh Alemi, Adel Ali Saeed Al-Gheethi, Abid Ali, Syed Shujait Shujait Ali, Jaber S Alqahtani, Mohammad AlQudah, Jaffar A. Al-Tawfiq, Yaser Mohammed Al-Worafi, Karem H Alzoubi, Reza Amani, Prince M Amegbor, Edward Kwabena Ameyaw, John H Amuasi, Abhishek Anil, Philip Emeka Anyanwu, Mosab Arafat, Damelash Areda, Reza Arefnezhad, Kendalem Asmare Atalell, Firayad Ayele, Ahmed Y Azzam, Hassan Babamohamadi, François-Xavier Babin, Yogesh Bahurupi, Stephen Baker, Biswajit Banik, Martina Barchitta, Hiba Jawdat Barqawi, Zarrin Basharat, Pritish Baskaran, Kavita Batra, Ravi Batra, Nebiyou Simegnew Bayileyegn, Apostolos Beloukas, James A Berkley, Kebede A Beyene, Ashish Bhargava, Priyadarshini Bhattacharjee, Julia A Bielicki, Mariah Malak Bilalaga, Veera R Bitra, Colin Stewart Brown, Katrin Burkart, Yasser Bustanji, Sinclair Carr, Yaacoub Chahine, Vijay Kumar Chattu, Fatemeh Chichagi, Hitesh Chopra, Isaac Sunday Chukwu, Eunice Chung, Sriharsha Dadana, Xiaochen Dai, Lalit Dandona, Rakhi Dandona, Isaac Darban, Nihar Ranjan Dash, Mohsen Dashti, Mohadese Dashtkoohi, Denise Myriam Dekker, Ivan Delgado-Enciso, Vinoth Gnana Chellaiyan Devanbu, Kuldeep Dhama, Nancy Diao, Thao Huynh Phuong Do, Klara Georgieva Dokova, Christiane Dolecek, Arkadiusz Marian Dziedzic, Tim Eckmanns, Abdelaziz Ed-Dra, Ferry Efendi, Aziz Eftekharimehrabad, David William Eyre, Ayesha Fahim, Alireza Feizkhah, Timothy William Felton, Nuno Ferreira, Luisa S Flor, Santosh Gaihre, Miglas W Gebregergis, Mesfin Gebrehiwot, Christine Geffers, Urge Gerema, Kazem Ghaffari, Mohamad Goldust, Pouya Goleij, Shi-Yang Guan, Mesay Dechasa Gudeta, Cui Guo, Veer Bala Gupta, Ishita Gupta, Farrokh Habibzadeh, Najah R Hadi, Emily Haeuser, Wase Benti Hailu, Ramtin Hajibeygi, Arvin Haj-Mirzaian, Sebastian Haller, Mohammad Hamiduzzaman, Nasrin Hanifi, Jan Hansel, Md Saquib Hasnain, Johannes Haubold, Nguyen Quoc Hoan, Hong-Han Huynh, Kenneth Chukwuemeka Iregbu, Md. Rabiul Islam, Abdollah Jafarzadeh, Ammar Abdulrahman Jairoun, Mahsa Jalili, Nabi Jomehzadeh, Charity Ehimwenma Joshua, Md. Awal Kabir, Zul Kamal, Kehinde Kazeem Kanmodi, Rami S. Kantar, Arman Karimi Behnagh, Navjot Kaur, Harkiran Kaur, Faham Khamesipour, M Nuruzzaman Khan, Mahammed Ziauddin Khan suheb, Vishnu Khanal, Khaled Khatab, Mahalaqua Nazli Khatib, Grace Kim, Kwanghyun Kim, Aiggan Tamene Tamene Kitila, Somayeh Komaki, Kewal Krishan, Ralf Krumkamp, Md Abdul Kuddus, Maria Dyah Kurniasari, Chandrakant Lahariya, Kaveh Latifinaibin, Nhi Huu Hanh Le, Thao Thi Thu Le, Trang Diep Thanh Le, Seung Won Lee, Alain LEPAPE, Temesgen L. Lerango, Ming-Chieh Li, Amir Ali Mahboobipour, Kashish Malhotra, Tauqeer Hussain Mallhi, Anand Manoharan, Bernardo Alfonso Martinez-Guerra, Alexander G. Mathioudakis, Rita Mattiello, Jürgen May, Barney McManigal, Steven M McPhail, Tesfahun Mekene Meto, Max Alberto Mendez Mendez-Lopez, Sultan Ayoub Meo, Mohsen Merati, Tomislav Mestrovic, Laurette Mhlanga, Le Huu Nhat Minh, Awoke Misganaw, Vinaytosh Mishra, Arup Kumar Misra, Nouh Saad Mohamed, Esmaeil Mohammadi, Mesud Mohammed, Mustapha Mohammed, Ali H Mokdad, Lorenzo Monasta, Catrin E Moore, Rohith Motappa, Vincent Mougin, Parsa Mousavi, Francesk Mulita, Atsedemariam Andualem Mulu, Pirouz Naghavi, Ganesh R Naik, Firzan Nainu, Tapas Sadasivan Nair, Shumaila Nargus, Mohammad Negaresh, Hau Thi Hien Nguyen, Dang H Nguyen, Van Thanh Nguyen, Taxiarchis Konstantinos Nikolouzakis, Efaq Ali Noman, Chisom Adaobi Nri-Ezedi, Ismail A. Odetokun, Patrick Godwin Okwute, Matifan Dereje Olana, Titilope O Olanipekun, Omotola O. Olasupo, Antonio Olivas-Martinez, Michal Ordak, Edgar Ortiz-Brizuela, Amel Ouyahia, Jagadish Rao Padubidri, Anton Pak, Anamika Pandey, Ioannis Pantazopoulos, Pragyan Paramita Parija, Romil R Parikh, Seoyeon Park, Ashwaghosha Parthasarathi, Ava Pashaei, Prince Peprah, Hoang Tran Pham, Dimitri Poddighe, Andrew Pollard, Alfredo Ponce-De-Leon, Peralam Yegneswaran Prakash, Elton Junio Sady Prates, Nguyen Khoi Quan, Pourya Raee, Fakher Rahim, Mosiur Rahman, Masoud Rahmati, Shakthi Kumaran Ramasamy, Shubham Ranjan, Indu Ramachandra Rao, Ahmed Mustafa Rashid, Sayaphet Rattanavong, Nakul Ravikumar, Murali Mohan Rama Krishna Reddy, Elrashdy Moustafa Mohamed Redwan, Robert C Reiner, Luis Felipe Reyes, Tamalee Roberts, Mónica Rodrigues, Victor Daniel Rosenthal, Priyanka Roy, Tilleye Runghien, Umar Saeed, Amene Saghazadeh, Narjes Saheb Sharif-Askari, Fatemeh Saheb Sharif-Askari, Soumya Swaroop Sahoo, Monalisha Sahu, Joseph W Sakshaug, Afeez Abolarinwa Salami, Mohamed A. Saleh, Hossein Salehi omran, Malik Sallam, Sara Samadzadeh, Yoseph Leonardo Samodra, Rama Krishna Sanjeev, Made Ary Sarasmita, Aswini Saravanan, Benn Sartorius, Jennifer Saulam, Austin E Schumacher, Seyed Arsalan Seyedi, Mahan Shafie, Samiah Shahid, Sunder Sham, Muhammad Aaqib Shamim, Mohammad Ali Shamshirgaran, Rajesh P. Shastry, Samendra P Sherchan, Desalegn Shiferaw, Aminu Shittu, Emmanuel Edwar Siddig, Robert Sinto, Aayushi Sood, Reed J D Sorensen, Andy Stergachis, Temenuga Zhekova Stoeva, Chandan Kumar Swain, Lukasz Szarpak, Jacques Lukenze Tamuzi, Mohamad-Hani Temsah, Melkamu B Tessema Tessema, Pugazhenthan Thangaraju, Nghia Minh Tran, Ngoc-Ha Tran, Munkhtuya Tumurkhuu, Sree Sudha Ty, Aniefiok John Udoakang, Inam Ulhaq, Tungki Pratama Umar, Abdurezak Adem Umer, Seyed Mohammad Vahabi, Asokan Govindaraj Vaithinathan, Jef Van den Eynde, Judd L Walson, Muhammad Waqas, Yuhan Xing, Mukesh Kumar Yadav, Galal Yahya, Dong Keon Yon, Abed Zahedi Bialvaei, Fathiah Zakham, Abyalew Mamuye Zeleke, Chunxia Zhai, Zhaofeng Zhang, Haijun Zhang, Magdalena Zielińska, Peng Zheng, Aleksandr Y Aravkin, Theo Vos, Simon I Hay, Jonathan F. Mosser, Stephen S Lim, Mohsen Naghavi, Christopher J L Murray, Hmwe Hmwe Kyu

Bienvenue sur EM-consulte, la référence des professionnels de santé.

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.